Arvinas, Inc. (ARVN)
12.99
-0.11
(-0.84%)
USD |
NASDAQ |
Dec 10, 16:00
12.90
-0.09
(-0.69%)
After-Hours: 20:00
Arvinas Cash from Investing (Quarterly): 63.50M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Assembly Biosciences, Inc. | -158.27M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Verastem, Inc. | -8.279M |
| Sarepta Therapeutics, Inc. | 232.40M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -59.10M |
| Cash from Financing (Quarterly) | -17.80M |
| Free Cash Flow Per Share (Quarterly) | -0.8087 |
| Free Cash Flow to Equity (Quarterly) | -58.60M |
| Free Cash Flow to Firm (Quarterly) | -59.20M |